Health ❯Healthcare ❯Clinical Trials ❯Drug Efficacy

Lecanemab

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs